Literature DB >> 8027323

Preliminary interpretive susceptibility testing criteria for FK-037 with 30-microgram disks.

R N Jones1.   

Abstract

FK-037, a new parenteral cephalosporin, was tested against 483 organisms from clinical infections to establish preliminary susceptibility testing criteria with 30-micrograms disks. The proposed breakpoint zone diameters were > or = 17 mm (MIC correlate, < or = 8 micrograms/ml) for the susceptible category and < or = 13 mm (MIC correlate, > or = 32 micrograms/ml) for the resistant category. These interpretive guidelines produced no very major (false-susceptible) errors, 2.9% major (false-resistant) errors, and 6.2% minor errors for a total absolute agreement between methods of 90.9%.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027323      PMCID: PMC267197          DOI: 10.1128/jcm.32.4.1104-1106.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  In vitro antibacterial spectrum of E1040 compared with those of cefpirome and ceftazidime and disk diffusion interpretive criteria for E1040.

Authors:  P C Fuchs; R N Jones; A L Barry
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

2.  Antimicrobial activity of FK-037 against class I beta-lactamase producing species resistant to ceftazidime: a multi-laboratory clinical isolate sample.

Authors:  M L Sanchez; R N Jones
Journal:  J Antimicrob Chemother       Date:  1993-10       Impact factor: 5.790

3.  Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.

Authors:  P C Fuchs; R N Jones; A L Barry; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

4.  In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin.

Authors:  R N Jones; C Thornsberry; A L Barry
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

5.  In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin.

Authors:  H C Neu; N X Chin; H B Huang
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

6.  In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad-spectrum cephalosporin.

Authors:  K P Fu; B D Foleno; S C Lafredo; J M LoCoco; D M Isaacson
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.